Colorectal Cancer Screening Rates Improve with Home Testing Kits
Colorectal cancer screening, while highly effective, is underutilized among patients at federally qualified health centers (FQHCs).
Read MorePosted by Chris Wolski | Nov 26, 2024 | Colorectal |
Colorectal cancer screening, while highly effective, is underutilized among patients at federally qualified health centers (FQHCs).
Read MorePosted by Andy Lundin | Oct 4, 2024 | Colorectal |
The FDA approved Exact Sciences’ Cologuard Plus test, a stool DNA test that enhances colorectal cancer and precancerous lesion detection.
Read MorePosted by Chris Wolski | Sep 25, 2024 | Colorectal |
Stool-based tests are promising alternatives to colonoscopy for colorectal cancer screening, addressing global accessibility challenges.
Read MorePosted by Andy Lundin | Jul 31, 2024 | Colorectal |
Researchers have identified geographic “hot spots” in the U.S. with low colorectal cancer screening rates among Hispanic/Latino communities.
Read MorePosted by Andy Lundin | Jul 11, 2024 | Colorectal |
The new collaboration aims to enhance colorectal cancer (CRC) screening using advanced diagnostic platforms and novel biomarkers.
Read More